DOCSLIB.ORG

Download the QUOSA Fact Sheet

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Fact Sheet Helping life science companies overcome information management issues The four pillars of QUOSA Who QUOSA supports • Automated collection and deduplication of full-text QUOSA is designed to facilitate information literature and other documents management for life sciences teams, including: • Easy organization of documents in a centralized, • Medical and regulatory affairs teams needing to rapidly cloud-based repository respond to queries • Searching of external sources and the QUOSA library • Research and discovery teams working with a large, • Support for copyright compliant sharing of resources shared knowledge base with the right teams • Drug and device safety teams focused Consolidating and standardizing literature locations and tools helps life sciences companies with research efficiency, saves on costs and streamlines critical regulatory workflows. It also supports compliant literature storage and sharing. QUOSA is a complete online information management solution designed for life sciences companies. It centralizes the process of collecting and sharing scientific information to ensure efficient and compliant use of the knowledge base. What does QUOSA do? Who is QUOSA for? QUOSA consolidates your external and internal literature QUOSA is specifically developed for life sciences companies resources into a single, centralized, scalable online library. in consultation with industry information professionals. It provides all the tools needed for efficiently organizing, This customizable end-to-end solution can meet your most searching, sharing and annotating information. demanding scientific literature management needs without You can use QUOSA to search other sources, including changing your existing workflows. Embase®, Scopus® and PubMed®, and retrieve references from them. You can also set email alerts to let you know about new Why choose QUOSA? documents that are relevant to your searches in those databases. QUOSA is designed to be a closed enterprise environment, QUOSA ensures that all stakeholders can answer the three ideal for the confidential information needed by teams essential questions in literature management: engaged in critical tasks, including: • Where is the literature? • Post-market surveillance of drugs and medical devices • How is it organized? • Medical and regulatory affairs and MSL research to respond to queries • Do we have the right to store and share full-text articles?* • Management of internal and external documentation in a * Provided CCC RightFind is integrated with QUOSA large knowledge base How does QUOSA work? QUOSA consolidates abstracts and full-text content from multiple sources, de-duplicating it to create a single, organized and more easily accessible library. Sources Medical a airs and MSLs Quickly nd information to rapidly respond to medical information queries. Conference documents Automatically download Review and organize for key Give users easy access to abstracts and full text. workows and global access. data and documents. Research and discovery Online literature databases Use data to support decisions in R&D, preclinical trials and competitive intelligence. Internal libraries Drug and device safety Screen and triage the literature for adverse events. What are the benefits of QUOSA? What’s next for QUOSA? • Stay current: Use alerts to stay current on product, market QUOSA is developing from an information management and competitive developments. solution to serve the knowledge management requirements of • Consolidate sources: Store scientific literature in a secure, life sciences companies. Features in development include the scalable, central environment. possibility to perform semantic and federated searches, and support for finding patterns, trends and other insights within • Access information anywhere: Your QUOSA life science your library. library can be accessed from any browser. • Increase tool efficiency: Easily search accessible services, including Embase, ScienceDirect, PubMed and OvidSP. • Manage high volumes of content: QUOSA de-duplicates content, preventing wasteful multiple purchases. • Stay copyright compliant: Ensure that all sharing of content complies with copyright allowances. • Collaborate successfully: Project teams can have their own space in QUOSA to manage and annotate shared documents. • Cite and write: Medical writers can insert citations from their QUOSA library directly into Microsoft Word documents. For more information, visit elsevier.com/quosa. QUOSA is a trademark of Elsevier, Inc. Embase is a trademark of Elsevier Limited. Scopus and ScienceDirect are trademarks of Elsevier B.V. PubMed is registered in the U.S. Patent and Trademark Office by the National Library of Medicine. Microsoft is a trademark of the Microsoft Corporation. Copyright © 2021, Elsevier. February 2021.
Recommended publications
  • Sciencedirect Empowering Researchers at Every Step

    Sciencedirect Empowering Researchers at Every Step

    ScienceDirect Empowering researchers at every step Training ScienceDirect for Institut Teknologi Bandung By Ujang Sanusi Customer Consultant ELSEVIER INDONESIA | 2 Elsevier is a world-leading Science, Health & Technology Information Provider CONTENT PROVISION ‘E’ CONTENT PROVISION RESEARCH MGMT SEARCH & DISCOVERY /PROMOTION TOOLS Niels Louis Alexander Albert George F. John C. Roger D. Craig C Mello Bohr Physics Pasteur Fleming Einstein Smoot Mather Kornberg Medicine (Chemistry) Medicine Physics Physics Physics Chemistry 2 | 3 Elsevier is engaging across the research workflow ScienceDirect – Extensive Multi-disciplinary Full-Text Database ScienceDirect is the largest online journal platform in the world with more than 2,500 journals in 24 subject areas owned and published by Elsevier and more than 33,000 eBooks. • Publishes over 25% of the world’s full-text scientific journals with several high- profile journal titles such as Cell, The Lancet and Tetrahedron • Over 13,859,000 articles are available online • It is also the most referenced journal platform in the world with an average of 25% citations coming from journals on ScienceDirect • Over 250,000 articles on ScienceDirect are open access Elsevier is the top scientific content provider of vital interdisciplinary information essential across industries and disciplines Scientific Research Articles Published Multi-disciplinary content Env Earth SciencesSciences #1 Global Provider ELS Life Sciences* 25% Soc Sciences Publish 25% of world’s journal articles Math & 2,500 active journals Comp
  • EMBASE Find Quick, Relevant Answers to Your Biomedical Questions

    EMBASE Find Quick, Relevant Answers to Your Biomedical Questions

    EMBASE Find quick, relevant answers to your biomedical questions Piotr Golkiewicz Solution Sales Manager Life Sciences Central and Eastern Europe and Russia Embase® is a registered trademark of Elsevier BV. WHAT IS EMBASE? THE WORLD’S MOST COMPREHENSIVE BIOMEDICAL RESEARCH TOOL Reliable and authoritative content to help the drug and drug-related research community advance new biomedical and pharmaceutical discoveries. Confidence Find all relevant articles that may not otherwise be found by using alternative databases Deep Biomedical Indexing All relevant, up-to-date, biomedical information from the research literature Precise Retrieval Deep and focused research using the most powerful retrieval tools 2 HOW EMBASE DELIVERS VALUE ...by including literature and Conference Scientific In Press We make sure you information resources in a proceedings Journals (unpublished) don’t miss any timely manner biomedical literature ...by reading full-text to The only close identify drugs, diseases, Deep indexing using own taxonomy alternative is adverse affects, clinical (EMTREE) reading trials, drug trade names etc. all the articles ...by enabling advanced search filters to drill down a Very powerful Good precision and comprehensive search to a recall balance relevant and manageable record Search Environment set ...by allowing users to automate Automation and searching and result management documentation E-mail Alerting API Interoperability 3 EMBASE CONTENT 4 EMBASE IS AS COMPREHENSIVE AS POSSIBLE SOURCE TEXT MINING EMBASE SCOPUS Effort / tools required / tools Effort PUBMED GOOGLE 0 % 50 % 100 % Percentage of relevant articles retrieved 5 COMPREHENSIVE CONTENT COVERAGE ON AVERAGE >5000 RECORDS ADDED EACH WORKDAY! Embase: Now covers over 8,400 journals Indexed at Embase (over 5,700 titles) Indexed by MEDLINE (e.g.
  • CLINICA CHIMICA ACTA International Journal of Clinical Chemistry and Diagnostic Laboratory Medicine

    CLINICA CHIMICA ACTA International Journal of Clinical Chemistry and Diagnostic Laboratory Medicine

    CLINICA CHIMICA ACTA International Journal of Clinical Chemistry and Diagnostic Laboratory Medicine AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.1 • Impact Factor p.1 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.4 ISSN: 0009-8981 DESCRIPTION . Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnosticapplication of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells. The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.
  • Searching EMBASE (Elsevier)

    Searching EMBASE (Elsevier)

    Searching EMBASE (Elsevier) EMBASE description • biomedical and pharmaceutical database • contains all of MEDLINE’s citations and many more unique citations • use when conducting systematic reviews or when searching for information on: food/diet/nutrition, medical devices, or drugs Access EMBASE 1. Go to Ruth Lilly Medical Library Databases. (https://iupui.libguides.com/az.php?s=83627) 2. Scroll down to click on, EMBASE (Elsevier), OR click “E” on the alphabet bar. 3. NOTE: If you are off campus, you will need to enter your university ID and password before you can access this resource. Basic search in EMBASE 1. Identify main concepts. 2. Type terms in the Quick Search Box. 3. Use a single or double quote around a phrase. 4. Use subject headings from EMTREE®. 5. Combine concepts using Boolean operators: AND, OR, NOT Boolean “AND” Boolean “OR” Boolean “NOT” Using AND will retrieve OR will retrieve more NOT will exclude fewer results (ex. heart attacks results (ex. heart attack unwanted terms (ex. AND aspirin) OR myocardial substance abuse NOT infarction) cigarettes). Table 1 Boolean AND, OR, and NOT visualized https://library.mednet.iu.edu/ (317) 274-7182 JCS 5/2020 Results page: Fine-tune your search Filter Results: Beneath the search box: If you click on Quick limits, you will have the options to limit your search to Human subjects and English language. Left-side bar: From most recent search, click each filter to see how many articles are in that subset: e.g. age, gender, drugs used, and other diseases. Work with Search History: • Combine searches using AND; OR • Select any search in History to recall the results.
  • Journals 2016 Catalog Directors’ Letter

    Journals 2016 Catalog Directors’ Letter

    MIT Press Journals 2016 catalog Directors’ Letter Dear Friends, The MIT Press celebrated its 50th anniversary in 2012, and the inclination to ponder our distinguished history remains strong, perhaps even more so this year with the change in Press leadership—Amy Brand was named Director of the MIT Press in July of 2015. The Press’s journals division, which was founded in 1972, ten years after the books division, also has a significant publishing legacy to consider, with over 80 journals published since the division’s inception. Some, such as Linguistic Inquiry and The Journal of Interdisciplinary History, have grown with us from the very beginning. Other core titles like International Security, October, The Review of Economics and Statistics and Journal of Cognitive Neuroscience joined the Press over the following decades, providing a solid base for the high-quality and innovative scholarship that our journals division is well known for. Today, we continue to push the boundaries of scholarly publishing and communication. We relish discovering new fields to publish in, and working with scholars who are establishing new domains of research and inquiry. In keeping with that spirit, the Press is proud to launch a new open access journal in 2016, Computational Psychiatry, to serve a burgeoning field that brings together experts in neuroscience, decision sciences, psychiatry, and computation modeling to apply new quantitative techniques to our understanding of psychiatric disorders. Developing new ways of delivering journal articles and providing a richer range of metrics around their usage and impact is another current effort. On our mitpressjournals.org site, the Press is providing Altmetric badges for select titles to give an improved sense of the breadth of a journal article’s reach.
  • View Document

    View Document

    11/07/2017 Embase Select Language ▼ Logout Session Results / Record 4 of 173 Full record Record 4 Similar records | Add to Clipboard | Email Record The utilisation of modern transport and telecommunications platforms to assist in the remote provision of paediatric cancer diagnostics in Tanzania Mcdermott M., O'Hare K., Scanlon P., Grehan D., Rooney S., Laiti R., Kaijage J., Jumanne S., O'Sullivan M. Pediatric Blood and Cancer 2016 63 Supplement 3 (S71) Go to publisher for the full text Abstract Background/Objectives: The acquisition of a pathologic diagnosis represents a critical point in the management of children with malignant disease, allowing staff to plan a therapeutic pathway. In resource poor settings, diagnoses help to identify children who will benefit from the limited interventions available and those who will not. Access to timely diagnoses can be a challenge in low and middle income countries. While enhanced local laboratory capacity is the ultimate answer, interim solutions are needed to assist programs with existing deficits. Modern transport and telecommunications technology can facilitate this process. Design/Methods: Muhimbili University, Dar es Salaam, provides a paediatric cancer program for Tanzania. As part of a formal twinning arrangement, laboratory staff in Dublin have provided interim diagnostic services while helping to develop local paediatric cancer diagnostic capacity in Tanzania. Samples are transported free via DHL® couriers. Preliminary reports are communicated to local clinical staff via WhatsApp with final reports scanned and e-mailed. Results: Since 2008, almost 1000 cancer samples have been transported from Dar to Dublin. Transport time is two working days. In 92% of cases, a preliminary communication regarding specimen adequacy and provisional diagnosis was communicated via WhatsApp the day after receipt.
  • Sciencedirect ® Sciencedirect Books: High Impact, Relevant Content

    Sciencedirect ® Sciencedirect Books: High Impact, Relevant Content

    ScienceDirect ® ScienceDirect Books: High impact, relevant content These days, a world of information is at our fingertips. Simple online searches return millions of pages that claim to provide expert, timely information. But we’ve all had the experience of wondering if the information is trustworthy, accurate and the best to address our needs. Even casual web searchers are left wondering how to decipher the irrelevant information that fills online search result pages, so what’s a serious researcher to do in a world of overwhelming content and underwhelming relevancy? Elsevier offers greater clarity and insights for researchers by putting their needs first. ScienceDirect: A maximum impact, trusted research solution that delivers ScienceDirect, Elsevier’s leading online full-text information solution, is more than just a research destination for scientists; it’s a continuously evolving, dynamic repository that is constantly updated with the very latest research data available on a variety of subjects. Using the latest technology, the platform provides users with the answers they need, when they need them across a broad range of topics in science, technology and health, helping users attain a greater depth of information than other research solutions provide. Our data driven approach A user focused perspective based on the workflow and understanding the needs of researchers to build our publishing strategy Elsevier offers greater clarity and insights for researchers decisions. By providing data and analysis of their by putting their needs first. A wide range of relevant institution’s usage behavior on ScienceDirect to identify content combined with cutting-edge technology on the content gaps, a clear picture of in-demand content ScienceDirect platform provides quick, easily accessible emerges.
  • Vol 42 Iss S1 April 2021 Vol 42 | Iss S1 | April 2021 Abstracts

    Vol 42 Iss S1 April 2021 Vol 42 | Iss S1 | April 2021 Abstracts

    Vol 42 Iss S1 April 2021 Vol Vol 42 | Iss S1 | April | 2021 Abstracts Top Six Abstracts T2 One Year Follow up Results of the DETECT Enzymatic Debridement Multicenter RCT T1 Initial Results of the American Burn Association (ABA) Multi-Center Evaluation William L. Hickerson, MD, Jeremy Goverman, MD, on the Effectiveness of the Burn Navigator Sigrid A. Blome-Eberwein, MD, Adam Singer, MD, Lucy Wibbenmeyer, MD, Nicholas Meyer, MD, Julie A. Rizzo, MD FACS, Maria L. Serio-Melvin, Joshua S. Carson, MD, FACS, James Gallagher, MD, MSN RN, Elsa Coates, MS, RN, CCRN, FACS, Steven Kahn, MD, Dhaval Bhavsar, MBBS, Nehemiah T. Liu, MS, Jose Salinas, PhD David Mozingo, MD, Tam N. Pham, MD, FACS, United States Army Institute of Surgical Research, Nicole S. Gibran, MD, FACS, Jeffrey W. Shupp, Fort Sam Houston, Texas MD, FACS, Kevin N. Foster, MD, MBA, FACS, Giavonni M. Lewis, MD, FACS, Julie Caffrey, DO, Introduction: The Burn Navigator (BN) is an FDA-cleared MS, FACOS, Yaron Shoham, MD clinical decision support tool used to aid fluid resuscitation Firefighters’ Regional Burn Center, Memphis, Tennes- after major burn injury. The BN provides users with hourly see; Massachusetts General Hospital, Boston, Massa- recommendations for fluid titration during the initial resus- chusetts; LVHN, Allentown, Pennsylvania; Renais- citation based on various factors. The objective of this multi- sance School of Medicine at Stony Brook University, center observational study was to evaluate the resuscitation Stony Brook, New York; University of Iowa Hospitals volumes and related outcomes of patients admitted to five & Clinics, Iowa City, Iowa; Columbia-St. Mary’s ABA verified burn centers who underwent intravenous fluid Milwaukee Campus, Milwaukee, Wisconsin; UF resuscitation utilizing the BN.
  • Sciencedirect's Advanced Recommender a Fruitful Academic—Industrial Partnership

    Sciencedirect's Advanced Recommender a Fruitful Academic—Industrial Partnership

    ScienceDirect's Advanced Recommender a Fruitful Academic—Industrial Partnership Martin Rajman Craig Scott EPFL Elsevier [email protected] [email protected] 1 Academic-Industrial partnership Martin Rajman • Executive Director of Nano-Tera.ch, a large Swiss Research Program funding collaborative multi- disciplinary projects for the engineering of complex systems in Health and the Environment. • Senior researcher at EPF Lausanne, Switzerland (EPFL). His research interests include Artificial Intelligence, Computational Linguistics and Data- driven Probabilistic Machine Learning. • Active in various large scale industry-research collaborations with majors economic players. EPFL • EPFL is one of the two Swiss Federal Institutes of Technology and is located in Lausanne, Switzerland. It is considered to be among the worlds most prestigious universities in technology. 2 Academic-Industrial partnership Craig Scott • Senior Product Manager, Academic & Government Research Markets (ScienceDirect, Scopus, Scirus) • Amsterdam, Netherlands • Working on ‘big data’ experiments, A/B testing, search technology • Science Technology & Medical division of Reed Elsevier Elsevier Customers in >180 countries (1/3 North America, 1/3 Europe, 1/3 RoW) Serving >30 million scientists, students, health and information professionals 3 General Context • Every day Elsevier records millions of data points on document downloads (or views) on about 12 million scientific publications • This represents extremely valuable information about the involved scientific community(ies)
  • Elsevier @Thebritishlibrary Sciencedirect Scopus

    Elsevier @Thebritishlibrary Sciencedirect Scopus

    The Business of E-Resources Publishing Michaela Kurschildgen, Customer Consultant Elsevier Hilton Leeds City, 7 June 2017 Looking at today 1. A short history of publishing 2. Who is Elsevier 3. Technological and Content Innovation 4. Launching a new Journal 5. Editorial & Marketing Policies 6. Editorial & Peer Review Process 7. The Economics of Publishing 8. Pricing Models 9. Delivering Electronic Content 10. Working with Consortia 11. Open Access 1. A short history of publishing | 4 Origins of Scholarly Publishing 1439 Henry 1580 March 6,1665 Gutenberg Oldenburg Founding of the Philosophical and (1618- 1677) House of Elzevir Transactions of moveable the Royal Society Founding Editor type and Commercial Publisher of the First true scholarly first scientific journal journal . Ability to create multiply, bulk copies of literature . Religious & liturgical manuscripts Secretay of RS 1663 sent manuscripts to experts ->peer review In Context: Scholarly Publishing Today Scientific,Technical and Medical communities around the world are united through STM Publishing Highly competitive industry Peer Reviewed Articles per Peer Reviewed Journals Year 19% 26% 74% 81% Other STM publishers Elsevier Other STM publishers Elsevier 5 Examples of our 3,800+ journal titles Role of scientific publications Journal publishing has thrived for over 340 years but the fundamental role of Publishers remains unchanged Registration Timestamp: person and time of any new matter Certification Peer review – stamp of approval by publisher, quality guarantee Dissemination Medium to share findings Elzevirianas circa 1629 Preservation First scientific journals published in 1665 Preserve and archive records of science Oldenburg saw four roles that the journal served for the Society 2.
  • Search Worksheet

    Search Worksheet

    Search Worksheet Search Steps 1. State the research topic/clinical question as an answerable question – use a consistent method to frame the question, such as PICO(M) or its variants. Refer to Tables 2 and 3 on the back side. 2. Identify appropriate databases – refer to Table 4 on the back side. Do not rely on a single database. 3. Identify possible search terms, keywords, and synonyms based on concepts identified in step 1. 4. Conduct the search in the selected databases – search each concept separately. Use: OR – Combines synonyms, related terms, or spelling variations for each concept. (OR means more.) AND – Combine concepts to find citations which are “about” all of the concepts. (AND means less.) 5. Apply limits to narrow search results to relevant citations 6. Refine and save search Table 1 – Organize your search plan. State the research topic/clinical question as an answerable question. Concepts Concept 1 Concept 2 Concept 3 Concept 4 Identify key concepts Identify subject headings for each key concept Identify keywords for each key concept Apply limits, i.e., Publication Types, Age Groups, Years, Language, etc. 213 - Dec-20 Table 2 – PICO(M) Components P Patient or Problem What is the important patient problem or condition? How would you describe the important characteristics of the patient? Intervention, Indicator, What do you want to do to help the patient? Do you want to consider a specific treatment, diagnostic test, exposure or risk I Exposure, Prognostic Factor factor? Is there a prognostic factor that might affect the
  • Elsevier, Bepress, and a Glimpse at the Future of Scholarly Communication Christine L Ferguson, Murray State University

    Elsevier, Bepress, and a Glimpse at the Future of Scholarly Communication Christine L Ferguson, Murray State University

    Murray State University From the SelectedWorks of Cris Ferguson 2018 Elsevier, bepress, and a Glimpse at the Future of Scholarly Communication Christine L Ferguson, Murray State University Available at: https://works.bepress.com/christine-l-ferguson/45/ Balance Point Elsevier, bepress, and a Glimpse at the Future of Scholarly Communication Cris Ferguson, Column Editor Director of Technical Services, Waterfield Library, Murray State University, Murray, KY 42071; phone: 270-809-5607; email: [email protected]; ORCID: http://orcid.org/0000- 0001-8410-6010 Keywords Elsevier; bepress; open access; Penn Libraries; Digital Commons; scholarly communications Abstract The acquisition of bepress by Elsevier in August 2017, while unpopular among many librarians, provides both companies opportunities for expansion and growth. This Balance Point column outlines some of the benefits to both companies and the reaction by the library community. Also addressed is the announcement by the Penn Libraries that they are searching for a new open source repository potentially to replace bepress’s Digital Commons. The column concludes with some discussion of Elsevier’s relationship with open access content and the impact of the acquisition on the scholarly communications infrastructure. On August 2, 2017, Elsevier announced its acquisition of bepress, the provider of the Digital Commons institutional repository platform. Digital Commons “allows institutions to collect, organize, preserve and disseminate their intellectual output, including preprints, working papers, journals or specific articles, dissertations, theses, conference proceedings and a wide variety of other data” (Elsevier, August 2, 2017). bepress’s other major service, the Experts Gallery Suite, focuses on showcasing the expertise and scholarship of faculty. At the time Elsevier acquired the company, bepress had more than 500 customers using Digital Commons, and over 100 institutions using the Experts Gallery Suite.